Sunovion Pharmaceuticals Inc. Announces FDA Approval of Aptiom (eslicarbazepine acetate) as Once-Daily Adjunctive Treatment of Partial-Onset Seizures

11-11-2013 Business Wire HealthComments (0)

AptiomPharmaceuticalSunovion

Sunovion Announces FDA Approval of Aptiom (eslicarbazepine acetate) as Once-Daily Adjunctive Treatment of Partial-Onset Seizures

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top